Vertical: HealthcareBase Year: 2018
Market Size (2018)
$24.94B
Projected (2025)
$67.96B
CAGR (2016–2025)
15.5%
Key Players
16+
Critical illness insurance is also known as dread disease policy. Critical illness insurance provides coverage against specific life-threatening diseases. Depending on the customers’ needs, insurance covers different critical illness conditions. Some of the critical illnesses which are usually covered under such a policy are heart attack, cancer, strokes, multiple sclerosis, kidney failure, major organ transplant, paralysis etc. One of the reasons that make critical illness insurance essential is the large cover it offers. It covers major critical illnesses with a different range of severity. Critical illness insurance provides a lump sum amount, which adds to its importance in managing healthcare expenses. The lump-sum is paid irrespective of the hospitalization bills. This amount can be utilized for post-hospitalization medication, transport, accommodation, at-home treatment, and other related expenses.
The increasing cases of critical illness and increasing out of pocket expenditure for the insured and uninsured population are expected to drive the growth of the critical illness insurance market. However, lack of awareness about critical illness insurance is expected to hamper the market growth during the forecast period.
The Critical Illness Insurance Market market is projected to grow at a CAGR of 15.5% from 2016 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe scope of the global critical illness insurance market study includes the market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on application and region.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2025)
InsightNorth America leads with $23.61B by 2025, while Asia Pacific is projected to grow fastest at a 16.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $1.11B | $2.33B | $4.16B | 15.8% | 6% |
| North America | $6.49B | $13.42B | $23.61B | 15.4% | 35% |
| Asia Pacific | $4.52B | $9.67B | $17.53B | 16.3% | 26% |
| Europe | $5.40B | $10.84B | $18.58B | 14.7% | 27% |
| South America | $853.21M | $1.81B | $3.27B | 16.1% | 5% |
| Rest of the World | $211.42M | $449.06M | $807.76M | 16.1% | 1% |
| Total | $18.58B | $38.52B | $67.96B | 15.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$67.96B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Cancer | $40.68B | 15.9% | 60% |
| Others | $10.60B | 13.9% | 16% |
| Heart Attack | $9.79B | 15.6% | 14% |
| Stroke | $6.89B | 15.5% | 10% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Critical Illness Insurance Market covering market dynamics, competitive landscape, and strategic outlook.
The Critical Illness Insurance Market market is projected to reach $67.96B by 2025, growing at 15.5% CAGR. The Cancer segment holds the largest share.
Critical illness insurance is a type of insurance in which the insurer comes in a contract to make a lump sum cash payment if the policyholder is diagnosed with some specific disease on a predetermined list as a part of the insurance policy. Critical illness insurance is also known as critical insurance cover.
The increasing cases of critical illnesses and increasing out-of-pocket expenditure for the insured and uninsured population are expected to drive the growth of the global critical illness insurance market. However, lack of awareness about critical illness insurance is expected to hamper the growth of the market.
Critical illness means any illness, disease, or health condition that is life-threatening and needs comprehensive care and continuous monitoring, often in intensive care. The global critical illness insurance market is expected to witness a profitable growth owing to the rise in the number of critical illness cases such as cancer, stroke, heart attack, and renal failure, among others.
Cancer has a major impact on society across the world. According to the National Cancer Institute, an estimated 1,735,350 new cases of cancer were diagnosed in the US and 609,640 people died from the disease in 2018. Moreover, according to the Cancer Research UK, there were approximately 8.8 million (52%) new cancer cases in males and 8.2 million (48%) new cancer cases in females in 2018, globally.
In addition to this, stroke is the third leading cause of death in the US. According to the Internet Stroke Center, more than 140,000 people die each year from stroke in the US. Furthermore, as per the Centers for Disease Control and Prevention (CDC), about 805,000 Americans have a heart attack each year.
The care and treatment plans of these critical diseases are expensive. For instance, an estimated national expenditure for cancer care in the US in 2017 was USD 147.3 billion. Without comprehensive health insurance coverage, patients’ OUT-OF-POCKET costs would be higher, and millions would be unable to afford the care they need. Critical illness insurance can protect patients financially. Thus, rising cases of life-threatening diseases along with their higher treatment cost is increasing the adoption of critical illness insurance, which in turn, is expected to drive the growth of this market.
The critical illness (CI) insurance plan provides coverage for critical illnesses that require treatment over a long period. With rapid progress in the detection of diseases, more people are diagnosed often than earlier. The introduction of genetic testing allows the early diagnosis of minor diseases. With this, the definitions used in CI contracts are weakened.
The CI ‘s concept to provide financial support only when life is threatened by severe disease is reduced. This creates pricing uncertainty and is challenging the current critical illness cover conditions. Tiered and reviewable critical illness insurance products play to this scenario exceptionally well. Ultimately though, these medical advances question the long-term viability of guaranteed critical illness products in their current form. However, the new therapeutics and the increased role of genomics in day-to-day medicine is likely to create opportunities for insurers and allow them to tailor services according to patients’ needs. This could prompt the third generation of CI products that sees insurers shift from providing broad compensation for individual health circumstances. This will also lead to the growth in enrollment in insurance plans in the coming years.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 110 companies operating in the Critical Illness Insurance Market market, including revenue, employee count, and market positioning where available.
Showing 110 of 110 companies
Liberty Mutual occupies a distinctive position: it is simultaneously a top-five US personal-lines carrier and a top-tier global commercial and specialty (re)insurer, funded by permanent mutual capital and a $121 billion investment portfolio managed in-house. That breadth is both its moat and its burden. The personal-lines franchise (Liberty Mutual, Safeco, State Auto, Comparion) gives scale, brand and cash generation; the commercial franchise (Global Risk Solutions, Ironshore, Liberty Specialty Markets, Liberty Mutual Reinsurance, Global Surety) gives cycle diversification and access to hard specialty markets; and Liberty Mutual Investments supplies a private-capital earnings stream that few P&C peers can replicate at this scale. The group has spent three years narrowing rather than broadening: exiting Brazil, the Andes, Western Europe, Northern Ireland, Thailand and Vietnam, shrinking US auto, and rebuilding underwriting discipline. FY2025's record 88.4% combined ratio and $6.8 billion net income validate the strategy. The open question is whether it can now grow again without re-importing the volatility it just removed. Liberty Mutual is a Boston-headquartered, policyholder-owned property and casualty (P&C) insurance group that ranks among the ten largest P&C insurers in the world by gross written premium and among the top ten US personal-auto and homeowners writers. It is structurally unusual for an institution of its scale: because it is organised as a Massachusetts mutual holding company, it has no shareholders, no listed equity, no share price, no earnings per share and no market capitalisation. Its "owners" are the members — the named insureds on in-force policies issued by eight designated Member Companies — whose rights are limited to voting for directors, participating in any distribution on liquidation or demutualisation, and receiving member dividends if declared. Capital is therefore raised only through retained earnings (unassigned equity), surplus notes and senior/junior subordinated debt issued by the intermediate holding company, Liberty Mutual Group Inc. ("LMGI"). This gives management an unusually long planning horizon and insulates it from quarterly equity-market pressure, but it also caps the speed at which the group can grow surplus and makes debt capacity, statutory surplus and rating-agency capital adequacy the binding constraints on strategy. Over 2023–2025 the group executed one of the largest underwriting turnarounds in the US market, moving from a 102.7% combined ratio in FY2023 to 88.4% in FY2025 while shrinking the top line by roughly $2.9 billion — a deliberate trade of volume for profit that management summarises in the internal mantra "integrity, profit, then growth." --- **The company's own description (Q4 2025 earnings release, "About Liberty Mutual Insurance"):** "At Liberty Mutual, we believe progress happens when people feel secure. For more than 110 years we have helped people and businesses embrace today and confidently pursue tomorrow by providing protection for the unexpected and delivering it with care. A Fortune 100 company with more than 40,000 employees in 27 countries and economies, we are the ninth largest global property and casualty insurer and generate more than $50 billion in annual consolidated revenue. We operate through three strategic business units: US Retail Markets… Global Risk Solutions… and Liberty Mutual Investments, deploying more than $100 billion of long-term capital globally across its integrated platform." **Independent characterisation.** Liberty Mutual is best understood as three financially interlocking businesses under one mutual capital structure. The first is a **US retail underwriting utility**. US Retail Markets (USRM) produced $26.5 billion of net written premium and $29.4 billion of revenue in FY2025. It sells personal auto, homeowners, renters and related coverages to individuals, plus small commercial lines to small businesses. Distribution is deliberately multi-channel and channel-conflicted by design: approximately 1,165 licensed employee "Comparion" agents, 1,063 licensed telesales counsellors, independent agents (principally under the Safeco and State Auto brands), third-party producers, direct online, and sponsored affinity groups. Economics are classic short-tail personal lines — high frequency, rapid repricing, heavy advertising intensity, and a loss ratio that responds within four to six quarters to rate and underwriting actions. The second is a **global commercial and specialty (re)insurer**. Global Risk Solutions (GRS) wrote $17.2 billion of net premium and generated $19.2 billion of revenue in FY2025 across five market segments: North America, Liberty International Insurance, Liberty Mutual Reinsurance, Global Surety and Other GRS. This business is broker-intermediated, longer-tail, more cyclical in pricing, and materially more exposed to social inflation and reserve risk. It is where the group's Lloyd's platform, wholesale excess-and-surplus capability (Ironshore) and global surety franchise sit. The third is **Liberty Mutual Investments (LMI)**, an in-house asset manager deploying more than $100 billion of general-account capital. LMI is not merely a treasury function: limited-partnership income alone contributed $2,161 million of pre-tax operating income in FY2025 (FY2024: $1,266 million), equal to roughly 22% of consolidated pre-tax operating income. LMI's private-equity, real-estate, private-credit and energy-transition portfolios are a genuine differentiator against listed peers whose boards constrain alternatives allocations. **Revenue model.** Revenue is overwhelmingly insurance premium plus investment return, not product, subscription or licensing. FY2025 revenue decomposed as: premiums earned $44,213 million (87.6%); net investment income $6,075 million (12.0%); fee and other revenues $1,033 million (2.0%); net realised losses $(856) million (−1.7%). Fee revenue is small and derives principally from partner-carrier referral programmes and servicing-carrier work for involuntary assigned-risk pools, self-insured customers and risk retention groups. **Value-chain position.** Liberty Mutual is a risk-bearing balance sheet that also owns distribution (Comparion, telesales, direct), claims handling, risk engineering and loss prevention, and asset management. It is a net buyer of reinsurance ($8,386 million ceded in FY2025) and, through Liberty Mutual Reinsurance, also a seller of reinsurance ($3,920 million assumed). It is a servicing carrier for state involuntary pools, which is why $3,056 million of gross reinsurance recoverables sit against state-mandated pools carrying no direct underwriting risk. **Customer types and end-markets.** Individuals and households (auto, home, renters); small businesses (BOP, workers compensation, commercial auto, general liability); mid-size and large corporates and multinationals (property, casualty, specialty, marine, energy, construction, aviation, D&O, E&O, trade credit, cyber); contractors, developers and public authorities (surety); other insurers and reinsurers (assumed reinsurance); and, through a global inland-marine programme, wireless-handset protection at consumer scale.
Company Headquarters: Switzerland Founded: 1872 Workforce: 54,000 Company Working: Zurich is one of the leading multi-line insurer providers in global and local markets. The company provides a broad range of life insurance products and services for property and casualty in more than 210 countries and regions. The key customers for Zurich’s services include small businesses, individuals, and mid-sized and big companies, as well as multinational corporations.
Company Headquarters: Columbus, GA Founded: 1955 Workforce: ~10,001 Company Working: Aflac Incorporated is a wide-ranging business holding company that provides supplemental insurance to individuals in the US and Japan. Aflac's products include critical illness insurance, vision insurance, life insurance, hospital insurance, short term disability insurance, accident insurance, cancer insurance, and fixed-benefit dental plans. The company has a number of subsidiaries, namely, AFLAC Insurance Services Company Limited, Continental American Insurance Company, Inc., American Family Life Assurance Co. of Columbus (Aflac), American Family Life Assurance Company of New York, and others through which it operates its business.
Company Headquarters: Paris, France Founded: 1816 Workforce: ~104,065 Company Working: AXA is engaged in global insurance, investment management, and other financial services. The company operates in five major segments, namely, life & savings, property & casualty, health, asset management, and banking. It operates in more than 61 countries globally. As of December 2018, the company had 105 million customers globally.
Company Headquarters: The Hague, Netherlands Founded: 1983 Workforce: ~26,543 Company Working: Aegon is multinational life insurance, pensions, and asset management company headquartered in the Netherlands. The company is also active in accident, supplemental health insurance, and general insurance. It operates in three business segments, namely, premium, investment, and fee and commission. It operates in more than 20 countries globally. As of December 2018, the company had 28.5 million customers across the globe.
Company Headquarters: Beijing, China Founded: 1949 Workforce: ~100,000 Company Working: China Life Insurance Company is a leading life insurance company in China. The company has four major operating segments as life insurance business (Life), health insurance business (Health), accident insurance business (Accident), and others. Its products and services include individual life insurance, group life insurance, and accident and health insurance. It also provides individual and group life insurance, annuity products, and accident and health insurance in China. The company had about 285 million long-term individual and group life insurance policies, annuity contracts, and long-term health insurance policies in force, as of December 2018. The company offers insurance services to more than 500 million customers.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
